Latest News about ABT
Recent news which mentions ABT
Earnings Scheduled For July 20, 2023
July 20, 2023
From Benzinga
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
July 10, 2023
Tickers
ABT
From Benzinga
From Benzinga
Abbott Scores FDA Nod For First Dual-Chamber Leadless Pacemaker To Treat Abnormal, Slow Heart Rhythms
July 05, 2023
Tickers
ABT
From Benzinga
From Benzinga
From Benzinga
3 Passive Income Stocks to Hold for the Next 20 Years
June 20, 2023
From Motley Fool
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
June 16, 2023
Tickers
ABT
From Benzinga
Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB Application
June 13, 2023
From Benzinga
From Motley Fool
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
June 01, 2023
From Benzinga
AI stock hype could create hidden risks in your portfolio. Here’s how a ‘quality’ strategy can help.
May 31, 2023
From MarketWatch
Quant Ratings Updated on 107 Stocks
May 30, 2023
From InvestorPlace
From Benzinga
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
May 24, 2023
From Benzinga
From Benzinga
Abbott's Baby Formula Brouhaha: Judge Says No Harm, No Foul in Contamination Controversy
May 23, 2023
Tickers
ABT
From Benzinga
Stereotaxis, Abbott Ink Pact To Combine Mapping & Robotic Tech: FDA Approves Abbott's Next-Gen Abalation Catheter
May 19, 2023
From Benzinga
Claims of PediaSure Boosting Children's Height Challenged in Lawsuit Against Abbott Laboratories
May 16, 2023
Tickers
ABT
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.